Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Orexin, Sleep, and Cognition in Alzheimer Disease: Non-REM Oscillatory Activity and Neural Resilience.

Neurology·2026
Same author

Landscape of copy number variants in Spanish people with dementia.

NPJ genomic medicine·2026
Same author

Quantitative sleep EEG identifies CSF core biomarker-related subgroups in Alzheimer's disease.

GeroScience·2026
Same author

[Translated article] Anticholinergic burden and its relationship with cognitive impairment in a neuropsychiatric unit.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2026
Same author

Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differences.

Alzheimer's research & therapy·2026
Same author

Addressing persistent symptoms in post-COVID condition: Through a multimodal intervention delivered in two technology-based formats.

Digital health·2026

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Farida Dakterzada1, Ricard López Ortega2, Nuria Tahan3

  • 1Hospital Universitari Santa Maria de Lleida, IRBLleida, Lleida, Spain.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括

血p-tau217显示了对阿尔茨海默病 (AD) 病理学的高诊断准确性. 这种血液生物标志物可以有效地选需要进一步腰部穿刺以确定AD诊断的患者.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经学 神经学
  • 生物标志物发现发现
  • 阿尔茨海默氏症疾病研究研究

背景情况:

  • 阿尔茨海默病 (AD) 诊断依赖于侵入性和昂贵的方法.
  • 需要准确和可访问的生物标志物来检测AD.

研究的目的:

  • 为了评估血p-tau217的诊断准确性,用于AD相关的病理.
  • 为了确定血p-tau217的最佳切断值,以区分AD和非AD条件.
  • 评估血p-tau217与脑脊液 (CSF) 粉样蛋白病理学的一致性.

主要方法:

  • 包括127名患有AD,轻度认知障碍 (MCI) 和非AD痴呆症的患者.
  • 使用Lumipulse平台测量了包括Aβ42,Aβ40,p-tau181和p-tau217在内的血和CSF生物标志物.
  • 进行了统计分析,以评估相关性和诊断准确性 (AUC).

主要成果:

  • 血p-tau217水平与CSF p-tau181和粉样蛋白病理学 (Aβ42/Aβ40) 有很强的相关性.
  • 血p-tau217在识别粉样蛋白病理方面表现出高的诊断准确性 (AUC 0.919),相当于CSF Aβ42/40.
  • 已确定的血p-tau217的切断值实现了AD诊断的高灵敏度 (94.7%) 和特异性 (93.9%).

结论:

  • 血p-tau217是一种非常准确的生物标志物,用于检测AD相关的病理.
  • 这种血液检查可以作为一个有价值的工具,用于查患者在腰部穿刺之前.
  • 这些发现支持在阿尔茨海默病的临床诊断中使用血p-tau217.